According to Kremer-Tal, MigVax is hoping for its oral vaccine to be market-ready within 12-18 months. The company is slated to start human trials for its vaccine by the end of the summer or the beginning of the fall, she added.
Read more here.
According to Kremer-Tal, MigVax is hoping for its oral vaccine to be market-ready within 12-18 months. The company is slated to start human trials for its vaccine by the end of the summer or the beginning of the fall, she added.
Read more here.
![[Superpedestrian in Forbes] Link E-Scooter Gets Impressive New Technology But Existential Sector Questions Linger](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
